Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May;28(5):513-514.
doi: 10.5005/jp-journals-10071-24639.

Eternal Hunt: Unravelling the Challenge of CRE, the Quest for Perfection Continues!

Siddannagoud Salotagi  1 , Abinaya Kannan  1 , Atul Jindal  1
Affiliations

Eternal Hunt: Unravelling the Challenge of CRE, the Quest for Perfection Continues!

Siddannagoud Salotagi et al. Indian J Crit Care Med. 2024 May.

Abstract

How to cite this article: Salotagi S, Kannan A, Jindal A. Eternal Hunt: Unravelling the Challenge of CRE, the Quest for Perfection Continues! Indian J Crit Care Med 2024;28(5):513-514.

Keywords: Carbapenem-resistant enterobacteriaceae; Hospital-acquired infections.

PubMed Disclaimer

Conflict of interest statement

Source of support: Nil Conflict of interest: None

References

    1. Vijayakumar M, Selvam V, Renuka MK, Rajagopalan RE. The comparative efficacy of ceftazidime–avibactam with or without aztreonam vs polymyxins for carbapenem-resistant Enterobacteriaceae Infections: a prospective observational cohort study. Indian J of Crit Care Med: Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine. 2023;27(12):923. doi: 10.5005/jp-journals-10071-24577. - DOI - PMC - PubMed
    1. Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ. Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections. Clin Infect Dis. 2023:ciad428. doi: 10.1093/cid/ciad428. - DOI - PubMed
    1. Soontaros S, Leelakanok N. Association between carbapenem-resistant Enterobacteriaceae and death: A systematic review and meta-analysis. Am J Infect Control. 2019;47(10):1200–1212. doi: 10.1016/j.ajic.2019.03.020. - DOI - PubMed
    1. Larcher R, Laffont-Lozes P, Roger C, Doncesco R, Groul-Viaud C, Martin A, et al. Last resort beta-lactam antibiotics for treatment of New-Delhi Metallo-Beta-Lactamase producing Enterobacterales and other Difficult-to-Treat Resistance in Gram-negative bacteria: A real-life study. Front Cell Infect Microbiol. 2022;5(12):1048633. doi: 10.3389/fcimb.2022.1048633. - DOI - PMC - PubMed
    1. Sun S, Chen K, Kong X, Tian W, Niu S. Genetic diversity and in vitro activity of aztreonam/avibactam and ceftazidime/avibactam against carbapenem-resistant Enterobacterales: A multi-centre study in Southwest China. Infect Drug Resist. 2022;1:2243–2251. doi: 10.2147/IDR.S357396. - DOI - PMC - PubMed

LinkOut - more resources